Using the thymoma dataset from the TCGA database, we analyzed IGF1R expression in the MG and non‐MG groups and found that IGF1R expression was lower in MG patients and was associated with a poor prognosis (p < 0.05). The gene discussed is IGF1R; the disease is myasthenia gravis.